Anna Törner is a Regulatory Affairs Strategist and founder of SDS Life Science, currently holding the position of VP Strategic Regulatory Affairs at SDS Life Science and serving on multiple boards, including Medivir AB and Akiram Therapeutics. With extensive experience in clinical trial design and regulatory affairs, Anna has previously worked with organizations such as the Norwegian Medical Products Agency and Folkhälsomyndigheten. Anna holds a Ph.D. in Medical Science from Karolinska Institutet and Master's degrees in Pharmacy and Mathematical Statistics from Uppsala University and Stockholm University, respectively. Anna embraces uncertainty and is dedicated to exploring new possibilities in the life science sector.
Location
Stockholm, Sweden